Bioequivalency Study of Anastrozole 1 mg Under Fed Conditions



Status:Completed
Conditions:Breast Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - 45
Updated:1/25/2018
Start Date:May 2006
End Date:June 2006

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Anastrozole 1 mg Tablets Under Fed Conditions

The objective of this study was to prove the bioequivalence of Anastrozole Tablet under fed
conditions


Inclusion Criteria:

- No clinically significant abnormal findings on the physical examination, medical
history, or clinical laboratory results during screening

Exclusion Criteria:

- Positive test for HIV, Hepatitis B, or Hepatitis C.

- Treatment with known enzyme altering drugs.

- History of allergic or adverse response to anastrozole or any comparable or similar
product.
We found this trial at
1
site
Bio-Kinetic Clinical Applications, Inc.
Springfield, Missouri 65802
?
mi
from
Springfield, MO
Click here to add this to my saved trials